Group One Trading’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-300
Closed -$14.6K – 8530
2025
Q3
$14.6K Hold
300
– – ﹤0.01% 6922
2025
Q2
$22.4K Sell
300
-1,000
-77% -$66.2K ﹤0.01% 6197
2025
Q1
$82.6K Sell
1,300
-1,600
-55% -$109K ﹤0.01% 4751
2024
Q4
$226K Buy
+2,900
New +$233K ﹤0.01% 3838
2024
Q3
– Sell
-100
Closed -$8.27K – 6906
2024
Q2
$8.27K Sell
100
-1,600
-94% -$141K ﹤0.01% 5727
2024
Q1
$145K Buy
+1,700
New +$133K ﹤0.01% 3819
2023
Q2
– Sell
-2,900
Closed -$240K – 7869
2023
Q1
$240K Sell
2,900
-1,600
-36% -$130K ﹤0.01% 3501
2022
Q4
$354K Buy
4,500
+900
+25% +$72.3K ﹤0.01% 3348
2022
Q3
$267K Buy
3,600
+300
+9% +$21.5K ﹤0.01% 3865
2022
Q2
$215K Sell
3,300
-200
-6% -$11.8K ﹤0.01% 4236
2022
Q1
$221K Buy
3,500
+500
+17% +$27.2K ﹤0.01% 4694
2021
Q4
$159K Sell
3,000
-12,500
-81% -$762K ﹤0.01% 5304
2021
Q3
$1.09M Sell
15,500
-500
-3% -$31.6K ﹤0.01% 3322
2021
Q2
$1.07M Buy
16,000
+13,900
+662% +$984K ﹤0.01% 3334
2021
Q1
$233K Sell
2,100
-1,800
-46% -$223K ﹤0.01% 4870
2020
Q4
$463K Buy
+3,900
New +$420K ﹤0.01% 3329

Other funds holding HAE

Group One Trading's HAE Position: Q2 2026 in Review

Group One Trading reduced its Haemonetics (HAE) stake by 86% in Q2 2026, selling an estimated $26.2K and leaving 69 shares worth $5.17K. The position accounts for ﹤0.01% of the portfolio, ranked #6718.

Group One Trading first reported a position in HAE in Q1 2014 and has held it in 14 quarters since. The position peaked at $230K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Group One Trading held 69 shares of Haemonetics worth $5.17K as of Q2 2026.
  • Group One Trading sold 408 Haemonetics shares in Q2 2026, an estimated $26.2K.
  • Haemonetics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6718 holding.
  • Group One Trading first reported a position in Haemonetics in Q1 2014 and has held it in 14 quarters since.
  • Group One Trading's Haemonetics position peaked at $230K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.